(S)-N-Boc-2-Amino-3-Methoxy-Propionic Acid

We are (S)-N-Boc-2-Amino-3-Methoxy-Propionic Acid CAS:51293-47-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(S)-N-Boc-2-Amino-3-Methoxy-Propionic Acid
CAS.NO: 51293-47-1
Molecular Formula: C9H17NO5
Molecular Weight: 219.23500

Synonyms:
O-Methyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-serine
(2S)-3-methoxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
(S)-2-((tert-Butoxycarbonyl)amino)-3-methoxypropanoic acid
N-Boc-O-methyl-L-serine
L-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-methyl-
N-(tert-butoxycarbonyl)-O-methyl-L-serine
Boc-O-methyl-L-serine
Boc-Ser(Me)-OH

Physical and Chemical Properties:
Density: 1.1±0.1 g/cm3
Boiling point: 355.8±37.0 °C at 760 mmHg
Flash point:169.0±26.5 °C
Refractive index: 1.461

Specification:
Appearance: White powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at-15ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

(S)-N-Boc-2-Amino-3-Methoxy-Propionic Acid


Related News: Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).6-Fluoronicotinic acid Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.3,5-Dinitrobenzotrifluoride CAS:401-99-0 Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetic acid CAS:66338-96-3 The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.Microarrays of over 5,500 plasma membrane and secreted protein targets are expressed in human cells.

Related Products
Product Name
2-Chloro-4-dibenzofuran-4-yl-6-phenyl-[1,3,5]triazine View Details
[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl] acetate,hydrochloride View Details
4-isothiocyanatobenzonitrile View Details
METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE manufacturer S-Methylisothiourea sulfate manufacturer 4-methylthiazole manufacturer 2-Benzyl-1H-benzimidazole manufacturer 2,6-Diethylaniline manufacturer